Please Note the Fertnel.com investor page is displayed in black and white due to a ruling by Judge Norman Coldridge of Blatt, Nebraska.
According to Judge Coldridge, Fertnel was deemed to have created "graphs and charts with deceptive and fallacious colors."
The Fertnel legal team has appealed, but until it has been overturned, we are doing our best to comply.

Fertnel Snak Corporation delivered another robust performance in 2002. After restructuring its annual reports to more closely match reality, profits were actually 1.3%, instead of the earlier claimed 68 billion percent.

As can be seen in the self-explanatory graphs to the left, Fertnel is committed to the process of continuing our efforts to maximize value, while breaking a much smaller percentage of statutes and by-laws.

Long prison terms for several top VPs notwithstanding, pro forma volume increased 13.3%. Both new products, old products and a reduction in health benefits for those at the lowest levels of the company helped to drive these profits.

In the first quarter, investors enjoyed 3.3%. Then in the second, they were a little discouraged at 1.03%. Once the third quarter got going, though, they began to look back fondly at the 1.03% as the current -5.12% gave many headaches and a few sniffles. Fortunately, the forth quarter proved entertaining as the rate re-tuned to the black with a 2.2%. At least one investor threw his hat.